Incyte Industry Symposium - Exploring precision medicine and multidisciplinary care in cholangiocarcinoma

Incyte Industry Symposium - Exploring precision medicine and multidisciplinary care in cholangiocarcinoma

Plenary Room "Roma"

Information

Welcome and Introductions

Chair: Professor Bruno Sangro

Cholangiocarcinoma: A rare cancer?

Professor Jesús Bañales

Multidisciplinary care: The role of the surgeon in cholangiocarcinoma

Professor Thomas Gruenberger

Molecular profiling: Challenges and opportunities in cholangiocarcinoma

Dr Teresa Macarulla

Targeted therapies: Managing advanced cholangiocarcinoma with precision

Dr Harpreet Wasan

Panel discussion, Q&A and closing remarks

Chair: Professor Bruno Sangro

IncyteIncyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines. Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia. For more information, visit Incyte.com and follow @Incyte.

Registered attendees

Lea Duwe
Lea Duwe
PhD fellowBiotech Research & Innovation Center, University of Copenhagen
MP
Madhukar Patel
Transplant and Hepatobiliary SurgeonUniversity of Texas Southwestern Medical Center
Marco Sanduzzi Zamparelli
Marco Sanduzzi Zamparelli
MD, PhDBCLC group, Liver Unit. Hospital Clinic of Barcelona

Log in